Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 271.06 million compared to CNY 270.79 million a year ago. Revenue was CNY 271.06 million compared to CNY 270.79 million a year ago. Net loss was CNY 20.53 million compared to net income of CNY 15.01 million a year ago. Basic loss per share from continuing operations was CNY 0.1404 compared to basic earnings per share from continuing operations of CNY 0.1072 a year ago. Diluted loss per share from continuing operations was CNY 0.1404 compared to diluted earnings per share from continuing operations of CNY 0.1072 a year ago.